Back to discover
Disease

Skin Diseases, Genetic

Late-stage therapeutic developmentEmerging research
MeSHSkin Diseases, Genetic
1
Publications
4
Clinical trials
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial with recent milestones (1 completed or reporting results).
Clinical Milestones1View
Results posted 1
Activity timeline1

Clinical trials

4 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
4
All trials
1
Active
3
Late-stage
3
Completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes2
  • Middle Cerebral Artery1
  • Stroke1
Leading journals1
  • Scientific reports1
Leading researchers8
  • Chang JY1
  • Ha SH1
  • Jeong S1
  • Kang DW1
  • Kim BJ1
  • Kim JS1
  • Kwon SU1
  • Park JY1
Affiliations (unnormalised)4
  • Asan Medical Center1
  • Gangneung Asan Hospital1
  • Gil Medical Center1
  • Hanyang University College of Medicine1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.

Identifiers
MeSHSkin Diseases, Genetic
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.